Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Medicines CO (MDCO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,647,098
  • Shares Outstanding, K 73,900
  • Annual Sales, $ 6,140 K
  • Annual Income, $ -123,160 K
  • 60-Month Beta 1.13
  • Price/Sales 424.76
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.73
  • Number of Estimates 2
  • High Estimate -0.73
  • Low Estimate -0.73
  • Prior Year -0.67
  • Growth Rate Est. (year over year) -8.96%

Price Performance

See More
Period Period Low Period High Performance
1-Month
32.46 +10.38%
on 05/22/19
37.75 -5.09%
on 06/05/19
+2.84 (+8.61%)
since 05/17/19
3-Month
26.15 +37.02%
on 03/25/19
37.75 -5.09%
on 06/05/19
+8.69 (+32.02%)
since 03/18/19
52-Week
16.69 +114.68%
on 12/21/18
41.57 -13.81%
on 07/17/18
-0.98 (-2.66%)
since 06/18/18

Most Recent Stories

More News
Alnylam Completes Enrollment in Phase III Study of Lumasiran

Alnylam (ALNY) completes enrollment in its ILLUMINATE-A phase III study on lumasiran for the treatment of adults and children with primary hyperoxaluria type 1.

ANIK : 40.48 (-0.10%)
MDCO : 35.83 (+0.03%)
ALNY : 73.02 (+2.13%)
REGN : 306.63 (-1.40%)
Uptrend Call Working As Medicines Comp Stock Rises 71.5% (MDCO)

SmarTrend identified an Uptrend for Medicines Comp (NASDAQ:MDCO) on January 25th, 2019 at $20.86. In approximately 5 months, Medicines Comp has returned 71.47% as of today's recent price of $35.76.

MDCO : 35.83 (+0.03%)
Alnylam Completes Rolling NDA Submission to FDA for Givosiran

Alnylam (ALNY) completes the rolling NDA submission to the FDA for givosiran, which is being evaluated for the treatment of acute hepatic porphyria.

MDCO : 35.83 (+0.03%)
ALNY : 73.02 (+2.13%)
NVS : 91.30 (+1.72%)
REGN : 306.63 (-1.40%)
Options Traders Expect Huge Moves in Medicines Company (MDCO) Stock

Investors need to pay close attention to Medicines Company (MDCO) stock based on the movements in the options market lately.

MDCO : 35.83 (+0.03%)
Alnylam Initiates Phase I Study on Hypertension Candidate

Alnylam (ALNY) initiates phase I study on ALN-AGT, an investigational RNAi therapeutic targeting angiotensinogen for the treatment of hypertension in high unmet need populations.

ANIK : 40.48 (-0.10%)
MDCO : 35.83 (+0.03%)
ALNY : 73.02 (+2.13%)
AGTC : 4.04 (+1.25%)
Best Relative Performance in the Pharmaceuticals Industry Detected in Shares of Intra-Cellular T (ITCI , MDCO , ZGNX , HZNP , LLY )

We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look...

ITCI : 13.91 (-1.70%)
MDCO : 35.83 (+0.03%)
ZGNX : 39.79 (-1.27%)
Top 5 Companies in the Pharmaceuticals Industry with the Best Relative Performance (MDCO , MNK , OMER , LCI , PRGO )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

MDCO : 35.83 (+0.03%)
MNK : 9.35 (+3.77%)
OMER : 16.77 (-0.89%)
The Medicines Company Presents Clinical Data Analyses for Inclisiran at 87th European Atherosclerosis Society Congress

--Late-breaking abstract presentation of ORION-2 study showed that inclisiran significantly lowered LDL-C without need to increase dose in homozygous familial hypercholesterolemia

MDCO : 35.83 (+0.03%)
Medicines Co. (MDCO) Up 17.1% Since Last Earnings Report: Can It Continue?

Medicines Co. (MDCO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

MDCO : 35.83 (+0.03%)
Look for Shares of Medicines Comp to Potentially Pullback after Yesterday's 2.36% Rise

Medicines Comp (NASDAQ:MDCO) traded in a range yesterday that spanned from a low of $33.77 to a high of $35.01. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of...

MDCO : 35.83 (+0.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Good. Long term indicators fully support a continuation of the trend.

See More Share

Trade MDCO with:

Business Summary

The Medicines Company is a biopharmaceutical company driven by an overriding purpose-to save lives and alleviate suffering by developing solutions for diseases with vast economic and social consequences. The Company's mission is to create transformational solutions to address the most pressing healthcare...

See More

Key Turning Points

2nd Resistance Point 36.76
1st Resistance Point 36.29
Last Price 35.83
1st Support Level 35.47
2nd Support Level 35.12

See More

52-Week High 41.57
Last Price 35.83
Fibonacci 61.8% 32.07
Fibonacci 50% 29.13
Fibonacci 38.2% 26.19
52-Week Low 16.69

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar